Our previous study revealed that RBM10 inhibits LUAD progression by regulating the Wnt/β-catenin signaling pathway, and RBM10 deficiency is associated with lung cancer metastasis, especially brain metastasis [20]. Here, RBM10 is linked to lung carcinoma.